Community Research and Development Information Service - CORDIS

Results 1 - 10 of 88
Order by: Results/page:
12 3 4 5 6 7 8 9 > 
European Medical Information Framework
ID: 115372
Start date: 2013-01-01, End date: 2018-06-30
In response to the need to tackle increasingly complex medical research questions, a growing amount of human health data is being collected, either in routine Electronic Healthcare Record (EHR) databases, through research-driven cohort studies, in biobanks or related efforts....
Programme: FP7-JTI
Record Number: 203707
Last updated on: 2017-11-22
Delivering  European Translational Information & Knowledge Management Services
ID: 115446
Start date: 2012-10-01, End date: 2018-09-30
Since its inception the IMI has funded over 30 public-private partnership projects. Many of these projects are centered upon data intensive translational research and are employing integrative analysis approaches to achieve their goals. Although a common KM platform for IMI p...
Programme: FP7-JTI
Record Number: 203709
Last updated on: 2017-11-22
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes
ID: 115010
Start date: 2009-10-01, End date: 2015-09-30
Rationale The inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma this bottleneck results from: a lack of useful and validated biomarkers, underperforming pre-clinical models, inadequate and incomplete sub...
Programme: FP7-JTI
Record Number: 203682
Last updated on: 2017-11-22
Incorporating real-life clinical data into drug development
ID: 115546
Start date: 2013-10-01, End date: 2017-03-31
When a new medicine reaches the market, it is accompanied by an extensive data package that provides information about the safety and efficacy of the medicine in a clinical trial setting. However, assessing the expected future value of the medicines when used in “real world” ...
Programme: FP7-JTI
Record Number: 203672
Last updated on: 2017-11-22
BeTheCuRE
[PROJECT] BTCURE - BeTheCuRE
ID: 115142
Start date: 2011-04-01, End date: 2017-03-31
BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal models have to develop the line with the different subsets of the human diseases in order to be optimally used for drug discovery and drug ev...
Programme: FP7-JTI
Record Number: 203688
Last updated on: 2017-11-22
Pharmaceutical Medicine Training Programme
ID: 115013
Start date: 2009-05-01, End date: 2014-04-30
"The proposed Pharmaceutical Medicine Training Programme provides a comprehensive solution for the complex needs of integrated drug development for all professionals involved, incl. physicians, pharmaceutical scientists,biologists, biometricians, health economists, and safety...
Programme: FP7-JTI
Record Number: 203685
Last updated on: 2017-11-21
European Lead Factory
[PROJECT] EUC²LID - European Lead Factory
ID: 115489
Start date: 2013-01-01, End date: 2018-05-31
The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental valida...
Programme: FP7-JTI
Record Number: 203710
Last updated on: 2017-11-21
Biomarkers For Enhanced Vaccine Safety
ID: 115308
Start date: 2012-03-01, End date: 2018-02-28
BioVacSafe is a concise consortium of selected academic, public, and SME participants used to co-working in industry-led projects, organised into focused Activity Cores to generate knowledge and tools to benchmark licensed vaccine reactogenicity, and create practical and gene...
Programme: FP7-JTI
Record Number: 203698
Last updated on: 2017-11-21
European Prevention of Alzheimer’s Dementia Consortium
ID: 115736
Start date: 2015-01-01, End date: 2019-12-31
Background: The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical...
Programme: FP7-JTI
Record Number: 203723
Last updated on: 2017-11-20
Accelerated Development of Vaccine benefit-risk  Collaboration in Europe
ID: 115557
Start date: 2013-10-01, End date: 2018-09-30
Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to support accelerated decision-making. Approach: To achieve this vision throu...
Programme: FP7-JTI
Record Number: 203713
Last updated on: 2017-11-20
12 3 4 5 6 7 8 9 > 
List retrieved on: 2017-11-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top